Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Robert Kaplan and Sander Greenland | 14 Sep 2022 A new bivalent COVID vaccine will become available this week. The FDA used results from mouse experiments and the original vaccine trials to reassure the public that the new boosters are safe. Is this evidence sufficient? Last week, along with an international group of physicians and…









